Literature DB >> 26408930

Familial hypercholesterolaemia: A global call to arms.

Antonio J Vallejo-Vaz1, Sreenivasa Rao Kondapally Seshasai2, Della Cole2, G Kees Hovingh3, John J P Kastelein3, Pedro Mata4, Frederick J Raal5, Raul D Santos6, Handrean Soran7, Gerald F Watts8, Marianne Abifadel9, Carlos A Aguilar-Salinas10, Asif Akram11, Fahad Alnouri12, Rodrigo Alonso13, Khalid Al-Rasadi14, Maciej Banach15, Martin P Bogsrud16, Mafalda Bourbon17, Eric Bruckert18, Josip Car19, Pablo Corral20, Olivier Descamps21, Hans Dieplinger22, Ronen Durst23, Tomas Freiberger24, Isabel M Gaspar25, Jaques Genest26, Mariko Harada-Shiba27, Lixin Jiang28, Meral Kayikcioglu29, Carolyn S P Lam30, Gustavs Latkovskis31, Ulrich Laufs32, Evangelos Liberopoulos33, Lennart Nilsson34, Børge G Nordestgaard35, John M O'Donoghue11, Amirhossein Sahebkar36, Heribert Schunkert37, Abdulla Shehab38, Mario Stoll39, Ta-Chen Su40, Andrey Susekov41, Elisabeth Widén42, Alberico L Catapano43, Kausik K Ray44.   

Abstract

Entities:  

Keywords:  Familial hypercholesterolaemia

Mesh:

Substances:

Year:  2015        PMID: 26408930     DOI: 10.1016/j.atherosclerosis.2015.09.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  37 in total

1.  Dyslipidemia in the Arabian Gulf and its Impact on Cardiovascular Risk Outcome.

Authors:  Khalid Al-Rasadi; Hilal Al-Sabti
Journal:  Oman Med J       Date:  2015-11

2.  PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

Authors:  Maciej Banach; Piotr Jankowski; Jacek Jóźwiak; Barbara Cybulska; Adam Windak; Tomasz Guzik; Artur Mamcarz; Marlena Broncel; Tomasz Tomasik; Jacek Rysz; Agnieszka Jankowska-Zduńczyk; Piotr Hoffman; Agnieszka Mastalerz-Migas
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

Review 3.  Guest Editorial: Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9.

Authors:  Antonio J Vallejo-Vaz
Journal:  Eur Cardiol       Date:  2018-08

Review 4.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

Review 5.  Knowns and unknowns in the care of pediatric familial hypercholesterolemia.

Authors:  Andrew C Martin; Samuel S Gidding; Albert Wiegman; Gerald F Watts
Journal:  J Lipid Res       Date:  2017-07-12       Impact factor: 5.922

Review 6.  Familial Hypercholesterolemia: Global Burden and Approaches.

Authors:  Lale Tokgozoglu; Meral Kayikcioglu
Journal:  Curr Cardiol Rep       Date:  2021-09-04       Impact factor: 2.931

Review 7.  The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.

Authors:  Yu Xiang; Li Mao; Mei-Ling Zuo; Gui-Lin Song; Li-Ming Tan; Zhong-Bao Yang
Journal:  Mediators Inflamm       Date:  2022-06-17       Impact factor: 4.529

Review 8.  Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.

Authors:  Nadeem Qureshi; Maria Luisa R Da Silva; Hasidah Abdul-Hamid; Stephen F Weng; Joe Kai; Jo Leonardi-Bee
Journal:  Cochrane Database Syst Rev       Date:  2021-10-07

Review 9.  Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.

Authors:  Gerald F Watts; Samuel S Gidding; Pedro Mata; Jing Pang; David R Sullivan; Shizuya Yamashita; Frederick J Raal; Raul D Santos; Kausik K Ray
Journal:  Nat Rev Cardiol       Date:  2020-01-23       Impact factor: 32.419

10.  ERICA: prevalence of dyslipidemia in Brazilian adolescents.

Authors:  José Rocha Faria Neto; Vivian Freitas Rezende Bento; Cristina Pellegrino Baena; Marcia Olandoski; Luis Gonzaga de Oliveira Gonçalves; Gabriela de Azevedo Abreu; Maria Cristina Caetano Kuschnir; Katia Vergetti Bloch
Journal:  Rev Saude Publica       Date:  2016-02-23       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.